Grace Therapeutics, Inc. (GRCE) dividends
GRCE on Nasdaq, Health Care
Sign in to get an email when it declares a dividend.
Grace Therapeutics, Inc. dividend: key facts
Own Grace Therapeutics, Inc.? See exactly what it will pay you
Add your shares to a free DiviCompass portfolio to see your next GRCE dividend in your own money, every payment month by month, and an email when it declares. Free for up to 10 holdings, no card needed.
Price history
End-of-day closes on Nasdaq in USD. Dots mark ex-dividend dates.
Dividend history
Declared dividends. Special dividends are marked and excluded from yield and forecasts.
Reported financials
Annual figures from filings, converted to units.
Results, reports and dividend announcements
Next 12 months
No dividends expected from the data available.
Estimate confidence: None
Company news
- Grace Therapeutics Announces Second Quarter 2027 Financial Results, Provides Business Update12 Nov 2026 · GlobeNewsWire
PRINCETON, N.J., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage biopharma company advancing GTx-104, a novel, injectable fo...
- Grace Therapeutics Announces Participation in Upcoming Industry and Investor Events in November 20265 Nov 2026 · GlobeNewsWire
PRINCETON, N.J., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, nov...
- ACS Technologies and the Evangelical Lutheran Church in America Expand Strategic Partnership to Deliver a Connected Ministry Experience3 Oct 2026 · Business Wire
FLORENCE, S.C.--(BUSINESS WIRE)-- #churchpayments--ACS Technologies (ACST), powered by Vanco, today announced the expansion of its strategic relationship with the Evangelical Lutheran Church in Americ...
- Vanco, ACS Technologies, and GCFA Strengthen Partnership Through Expanded Ministry Ecosystem26 Sep 2026 · Business Wire
FLORENCE, S.C.--(BUSINESS WIRE)-- #churchchms--Vanco, ACS Technologies (ACST), and the General Council on Finance and Administration (GCFA) are strengthening their partnership through an expanded mini...
- Grace Therapeutics files to sell 4.76M shares of common stock for holders15 Sep 2026 · TheFly
This filing relates to the offer and sale from time to time by the selling stockholders of up to 4.76M shares of common stock. The company is not selling anyâ¦
- Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference15 Sep 2026 · GlobeNewsWire
PRINCETON, N.J., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, no...
- Grace Therapeutics to issue 4.762M shares at $2.10 in private placement16 Aug 2026 · TheFly
Grace Therapeutics (GRCE) announced that it has entered into a securities purchase agreement for a private placement financing with new and existing fundamental investors. The financing is expected to...
- Grace Therapeutics receives Type A meeting minutes from FDA16 Aug 2026 · TheFly
Grace Therapeutics (GRCE) announced receipt of the FDA meeting minutes from a Type A meeting held with the FDA to discuss the complete response letter, or CRL, issued on Aprilâ¦
Insufficient verified data for a financial-health score
Dividend data and price last updated 18 Nov 2026.